Finland – Pharmaceutical products – Hepcludex (bulevirtidi) -lääkevalmisteen valinta ajalle 1.4.2025-31.12.2025 Pohjoi
Pohjois-Pohjanmaan hyvinvointialue awarded €64.0K to Gilead Sciences Finland Oy for Healthcare & Medical in January 2026 — one of 366 awards this buyer has made, below its typical award size.
Buying agency
Pohjois-Pohjanmaan hyvinvointialueWinning supplier
Gilead Sciences Finland OyContract description
Finland – Pharmaceutical products – Hepcludex (bulevirtidi) -lääkevalmisteen valinta ajalle 1.4.2025-31.12.2025 Pohjois-Pohjanmaan hyvinvointialueen lääkehankintarenkaalle.
Related awards · Pohjois-Pohjanmaan hyvinvointialue
366 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-672047-2025Veho Oy Ab€10.7M13 Oct 2025 Healthcare
- ocds-ted-415080-2026NCC Suomi Oy€10.0M17 Jun 2026 Construction
- ocds-ted-720042-2025Rakennusliike LAPTI Oy€8.7M31 Oct 2025 Construction
Other wins · Gilead Sciences Finland Oy
11 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-18491-2025HUS-Yhtymä€3.0M13 Jan 2025 Healthcare
- ocds-ted-125915-2024HUS-Yhtymä€1.2M29 Feb 2024 Professional Services
- ocds-ted-121114-2024HUS-Yhtymä€1.0M28 Feb 2024 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Pohjois-Pohjanmaan hyvinvointialue and Gilead Sciences Finland Oy — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back